Clinical Trial Update: Effects Zulresso on Postpartum Psychosis [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 trial evaluating Zulresso (brexanolone) for postpartum psychosis has completed, sponsored by the University of North Carolina at Chapel Hill.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postpartum Psychosis

Drugs mentioned

• Zulresso (brexanolone)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Postpartum Psychosis | EARLY_Phase 1 | Status: COMPLETED